Federal Bureaucracy Drives Jobs Overseas
U.S. Chamber SBN
The New York Times this week reported that innovative medical device companies in the United States are losing their competitive edge, moving overseas, and even shutting down altogether because of the FDA’s slower, more stringent approval process compared to that of Europe’s. Read the full article here http://www.nytimes.com/2011/02/10/business/10device.html?_r=1&pagewanted=1.
Anyone in the medical device business witnessed this?







